Cargando…
Novel implications in the treatment of hepatocellular carcinoma
Worldwide hepatocellular carcinoma remains one of the leading causes of cancer-related death, associated with a poor prognosis due to late diagnosis in the majority of cases. Physicians at care are frequently confronted with patients who are ineligible for curative treatment such as liver resection,...
Autores principales: | Best, Jan, Schotten, Clemens, Theysohn, Jens M., Wetter, Axel, Müller, Stefan, Radünz, Sonia, Schulze, Maren, Canbay, Ali, Dechêne, Alexander, Gerken, Guido |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hellenic Society of Gastroenterology
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5198244/ https://www.ncbi.nlm.nih.gov/pubmed/28042235 http://dx.doi.org/10.20524/aog.2016.0092 |
Ejemplares similares
-
Partial spleen embolization reduces the risk of portal hypertension-induced upper gastrointestinal bleeding in patients not eligible for TIPS implantation
por: Buechter, Matthias, et al.
Publicado: (2017) -
Bridging treatment prior to liver transplantation for hepatocellular carcinoma: radioembolization or transarterial chemoembolization?
por: Benkö, Tamás, et al.
Publicado: (2022) -
Long-Term Outcome After Liver Transplantation for Hepatocellular Carcinoma Following Yttrium-90 Radioembolization Bridging Treatment
por: Radunz, Sonia, et al.
Publicado: (2017) -
Radioembolization with Y-90 Glass Microspheres: Do We Really Need SPECT-CT to Identify Extrahepatic Shunts?
por: Theysohn, Jens M., et al.
Publicado: (2015) -
LiMAx Prior to Radioembolization for Hepatocellular Carcinoma as an Additional Tool for Patient Selection in Patients with Liver Cirrhosis
por: Leyh, Catherine, et al.
Publicado: (2022)